Clinical Trial: A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Rheumatoid Arthritis
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging, Efficacy and Safety Study of SAR441566 Plus Methotrexate in Adults With ModeratetoSevere Rheumatoid Arthritis
Brief Summary:
This is a parallel group, Phase 2, randomized, double-blind, placebo controlled, 5-arm, international, multicenter, 12-week proof of concept, dose finding study.It is designed to assess efficacy and safety of treatment with SAR441566 for 12 weeks.It will be conducted in male and female adult participants with moderate-to-severe rheumatoid arthritis (RA) not adequately controlled on methotrexate (MTX) and biologic/targeted synthetic disease modifying anti-rheumatic drug (DMARD) naive.Study treatment includes…
Read more